A new preclinical model offers a unique platform for studying the Parkinson's disease process and suggests a relatively easy method for detecting the disease in people. A new preclinical model offers ...

A medication that has been prescribed in the U.S. for decades may be able to stop the earliest steps of Alzheimer’s disease— but only if it is taken long before symptoms appear, according to new ...

A work group convened by the Alzheimer's Association has released revised biology-based criteria for the diagnosis and staging of Alzheimer's disease (AD), including a new biomarker classification ...

Beta-amyloid plaques are considered a hallmark of Alzheimer’s disease, but they’re not the sole cause of the disease and its symptoms. Alzheimer’s is a complicated disease that experts are still ...

Huntington’s disease (HD) is one of those rare conditions that affects not just the patient but the entire family—medically, emotionally and genetically. This inherited brain disorder causes gradual ...

Researchers have developed a way to study aged neurons in the lab without a brain biopsy, allowing them to accurately model the effects of aging in the development of late-onset Alzheimer's disease.

Please provide your email address to receive an email when new articles are posted on . Ianalumab bested placebo in ESSDAI score at 48 weeks among patients with Sjögren’s disease. Monthly ianalumab ...